Connection

Michelle Mello to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications Michelle Mello has written about United States Food and Drug Administration.
Michelle Mello
Connection Strength
0.361
United States Food and Drug Administration
  1. Diagnostic Testing for the Novel Coronavirus. JAMA. 2020 Apr 21; 323(15):1437-1438.
    View in: PubMed
    Score: 0.120
  2. Behind Schedule - Reconciling Federal and State Marijuana Policy. N Engl J Med. 2018 Aug 09; 379(6):501-504.
    View in: PubMed
    Score: 0.106
  3. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. BMJ Open. 2017 Dec 05; 7(12):e017917.
    View in: PubMed
    Score: 0.102
  4. Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis. BMJ Open. 2021 07 19; 11(7):e053248.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.